Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183352 · ClinicalTrials.gov registry record
Reproductive Function and Mood in Women With Bipolar Disorder
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 90
- Enrollment target
NCT00183352: Completed study, sponsored by Stanford University.
NCT00183352 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00183352 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
This study will determine the effect of medication for bipolar disorder on the reproductive function and whether mood changes occur during the menstrual cycle in women with bipolar disorder.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2004-01 |
| Est. Completion | 2008-07 |
What the finished NCT00183352 record still lists
NCT00183352 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00183352 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00183352 about?
NCT00183352 is a clinical study titled "Reproductive Function and Mood in Women With Bipolar Disorder". This study will determine the effect of medication for bipolar disorder on the reproductive function and whether mood changes occur during the menstrual cycle in women with bipolar disorder.
What is the current status of trial NCT00183352?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2004-01. Estimated completion is 2008-07.
Who is sponsoring clinical trial NCT00183352?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia